![]() |
市場調查報告書
商品編碼
2114218
PTCA球囊導管市場:市場規模、佔有率、監管、報銷、治療方法及細分市場預測(至2036年)PTCA Balloon Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
經皮冠狀動脈腔內成形術(PTCA)是一種無需開胸手術即可恢復阻塞冠狀動脈血流的介入治療方法。此手術通過擴張導管末端的球囊,壓迫阻塞的斑塊,因而疏通血管。由於其微創性,PTCA已成為主要的介入治療方式。
本報告提供39個目標國家的彩色編碼、引證市場模型,包括基於流行病學資料的按適應症分類的治療統計資料。互動式Excel資料包含市場規模(價值和銷售)、產品使用情況、平均售價以及公司佔有率/排名分析(如有)。此外,分析師的定性評論說明了定量數據的背景和市場環境。
市場模式的主要內容
目前可用的PTCA球囊導管及不斷變化的競爭格局:
全球、區域和國家/地區特定市場洞察:
一份真正全面的整體情況,包括對醫療保健系統的概要介紹,將加深您對市場的理解。市場進入部分則透過提供有關報銷政策和法規環境的信息,對市場趨勢進行更詳細的分析。
目標公司:Shockwave Medical Inc, Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, B. Braun Melsungen AG, Biotronik SE & Co KG, Terumo Corp, Koninklijke Philips NV, Microport Scientific Corp, Lepu Medical Technology (Beijing) Co Ltd, OrbusNeich, Nipro Corp, Cordis Corp, iVascular SLU等
目標國家:美國、英國、德國、法國、義大利、西班牙、巴西、中國、印度、俄羅斯、日本、澳洲、加拿大、墨西哥、韓國、丹麥、愛爾蘭、荷蘭、紐西蘭、南非、瑞典、瑞士、奧地利、比利時、芬蘭、以色列、挪威、波蘭、葡萄牙、台灣、捷克、希臘、匈牙利、土耳其、埃及、沙烏地阿拉伯、阿拉伯聯合大公國、阿根廷、智利
運用這種市場模式,可以達成以下目標:
PTCA Balloon Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.
Percutaneous Transluminal Coronary Angioplasty (PTCA) is a intervention that helps restore blood flow to the blocked coronary artery without the requirement of open-heart surgery. In this intervention, a balloon at the end of a catheter is expanded to open the blocked coronary artery by compressing the plaque. PTCA has become the basic interventional modality because of its minimally invasive nature.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed PTCA Balloon Catheters and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Shockwave Medical Inc, Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, B. Braun Melsungen AG, Biotronik SE & Co KG, Terumo Corp, Koninklijke Philips NV, Microport Scientific Corp, Lepu Medical Technology (Beijing) Co Ltd, OrbusNeich, Nipro Corp, Cordis Corp, iVascular SLU and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -